Literature DB >> 19259671

Endoprosthetic reconstruction using total femoral custom mega prosthesis in malignant bone tumours.

Mayil Vahanan Natarajan1, Navin Balasubramanian, Viswanath Jayasankar, Mohammad Sameer.   

Abstract

We analysed 17 patients with primary malignant bone tumour of the femur who underwent limb salvage surgery with the total femoral custom mega prosthesis during the period 1994-2008. The patients were in the age group of 12-73 years, with a mean age of 30.94 years. There were 14 males. The most common diagnosis was osteosarcoma. The average follow-up period was 54.05 months with the longest being 168 months. The average Musculoskeletal Tumour Society (MSTS) functional score was 66.6%. The two- to 14-year overall survival was 82.4%. Three patients died of disease and one patient required amputation. Complications encountered were deep infection and dislocation of the prosthesis.

Entities:  

Mesh:

Year:  2009        PMID: 19259671      PMCID: PMC2899109          DOI: 10.1007/s00264-009-0737-x

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  15 in total

Review 1.  Megaprostheses for the treatment of malignant bone tumours of the lower limbs.

Authors:  Christian Heisel; Stefan Kinkel; Ludger Bernd; Volker Ewerbeck
Journal:  Int Orthop       Date:  2006-09-12       Impact factor: 3.075

2.  More than 10 years of follow-up of two patients after total femur replacement for malignant bone tumor.

Authors:  S Nakamura; K Kusuzaki; H Murata; H Takeshita; M Hirata; S Hashiguchi; Y Hirasawa
Journal:  Int Orthop       Date:  2000       Impact factor: 3.075

3.  Total femoral replacement.

Authors:  J Nerubay; A Katznelson; T Tichler; Z Rubinstein; B Morag; J J Bubis
Journal:  Clin Orthop Relat Res       Date:  1988-04       Impact factor: 4.176

4.  Massive allografts in tumour surgery.

Authors:  Z Matejovsky; Z Matejovsky; I Kofranek
Journal:  Int Orthop       Date:  2006-09-30       Impact factor: 3.075

5.  Limb-salvage treatment versus amputation for osteosarcoma of the distal end of the femur.

Authors:  M A Simon; M A Aschliman; N Thomas; H J Mankin
Journal:  J Bone Joint Surg Am       Date:  1986-12       Impact factor: 5.284

6.  [Modular system for the total replacement of the femur--Endo-model].

Authors:  E Nieder; E Engelbrecht; K Steinbrink; A Keller
Journal:  Chirurg       Date:  1983-06       Impact factor: 0.955

7.  Functional outcome in amputation versus limb sparing of patients with lower extremity sarcoma: a matched case-control study.

Authors:  A M Davis; M Devlin; A M Griffin; J S Wunder; R S Bell
Journal:  Arch Phys Med Rehabil       Date:  1999-06       Impact factor: 3.966

8.  A system of staging musculoskeletal neoplasms.

Authors:  W F Enneking
Journal:  Clin Orthop Relat Res       Date:  1986-03       Impact factor: 4.176

9.  Proximal femoral reconstruction with custom mega prosthesis.

Authors:  M Natarajan; J C Bose; G Rajkumar
Journal:  Int Orthop       Date:  2003-03-26       Impact factor: 3.075

10.  Use of extendable total femoral replacements in children with malignant bone tumors.

Authors:  O S Schindler; S R Cannon; T W Briggs; G W Blunn; R J Grimer; P S Walker
Journal:  Clin Orthop Relat Res       Date:  1998-12       Impact factor: 4.176

View more
  13 in total

1.  Total Femur Replacement After Tumor Resection: Limb Salvage Usually Achieved But Complications and Failures are Common.

Authors:  Florian Sevelda; Reinhard Schuh; Jochen Gerhard Hofstaetter; Martina Schinhan; Reinhard Windhager; Philipp Theodor Funovics
Journal:  Clin Orthop Relat Res       Date:  2015-04-02       Impact factor: 4.176

2.  Total femur prosthesis in oncological and not oncological series. Survival and failures.

Authors:  Francesco Muratori; Nicola Mondanelli; Xhulio Prifti; Guido Scoccianti; Giuliana Roselli; Filippo Frenos; Rodolfo Capanna; Domenico Andrea Campanacci
Journal:  J Orthop       Date:  2019-11-12

3.  The push-through total femoral prosthesis offers a functional alternative to total femoral replacement: a case series.

Authors:  Jelle Gorter; Joris J W Ploegmakers; Bas L E F Ten Have; Hendrik W B Schreuder; Paul C Jutte
Journal:  Int Orthop       Date:  2017-03-30       Impact factor: 3.075

4.  Custom-made endoprosthetic total humerus reconstruction for musculoskeletal tumours.

Authors:  Mayil Natarajan; Mohamed Sameer; Dheep Kunal; Navin Balasubramanian
Journal:  Int Orthop       Date:  2011-07-28       Impact factor: 3.075

Review 5.  High infection rate outcomes in long-bone tumor surgery with endoprosthetic reconstruction in adults: a systematic review.

Authors:  Antonella Racano; Theresa Pazionis; Forough Farrokhyar; Benjamin Deheshi; Michelle Ghert
Journal:  Clin Orthop Relat Res       Date:  2013-02-12       Impact factor: 4.176

6.  Large volume osteosarcomas of the femur treated with total femoral replacement.

Authors:  Kl Pan; Wh Chan; P Shanmugam; Gb Ong; F Kamaruddin; S Tan
Journal:  Malays Orthop J       Date:  2014-03

7.  Functional and oncologic outcomes after excision of the total femur in primary bone tumors: Results with a low cost total femur prosthesis.

Authors:  Ajay Puri; Ashish Gulia; Wai Hoong Chan
Journal:  Indian J Orthop       Date:  2012-07       Impact factor: 1.251

8.  Prophylactic antibiotic regimens in tumour surgery (PARITY): protocol for a multicentre randomised controlled study.

Authors:  Michelle Ghert; Benjamin Deheshi; Ginger Holt; R Lor Randall; Peter Ferguson; Jay Wunder; Robert Turcotte; Joel Werier; Paul Clarkson; Timothy Damron; Joseph Benevenia; Megan Anderson; Mark Gebhardt; Marc Isler; Sophie Mottard; John Healey; Nathan Evaniew; Antonella Racano; Sheila Sprague; Marilyn Swinton; Dianne Bryant; Lehana Thabane; Gordon Guyatt; Mohit Bhandari
Journal:  BMJ Open       Date:  2012-11-28       Impact factor: 2.692

9.  Total femoral reconstruction with custom prosthesis for osteosarcoma.

Authors:  Tang Liu; Xianghong Zhang; Qing Zhang; Xiangsheng Zhang; Xiaoning Guo
Journal:  World J Surg Oncol       Date:  2016-03-31       Impact factor: 2.754

10.  Short- to long-term follow-up of total femoral replacement in non-oncologic patients.

Authors:  Andreas Toepfer; Norbert Harrasser; Isabel Petzschner; Florian Pohlig; Ulrich Lenze; Ludger Gerdesmeyer; Dominik Pförringer; Marcel Toepfer; Marc Beirer; Moritz Crönlein; Ruediger von Eisenhart-Rothe; Heinz Mühlhofer
Journal:  BMC Musculoskelet Disord       Date:  2016-12-12       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.